Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sirolimus-eluting stent (Cypher)
DEVICE
2 trials
Sponsors
Deutsches Herzzentrum Muenchen
, Seoul National University Hospital
Conditions
Coronary Artery Disease
Coronary Disease
Phase 4
Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)
Completed
NCT00146575
Deutsches Herzzentrum Muenchen
Coronary Disease
Start: 2003-06-30
End: 2005-02-28
Updated: 2008-01-11
Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing
NCT00698607
Seoul National University Hospital
Coronary Artery Disease
Start: 2008-06-30
End: 2014-04-30
Target: 1466
Updated: 2010-06-29
Related Papers
Impact of PRECISE-DAPT and DAPT Scores on Dual Antiplatelet Therapy Duration After 2nd Generation Drug-Eluting Stent Implantation.
2021-04-01
3 citations
SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era
Korean Circulation Journal
2019-10-04
12 citations
Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome
PLoS ONE
2018-11-26
16 citations
Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention - 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial.
2017-09-30
3 citations
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
2011-12-16
443 citations
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.
2011-10-01
100 citations